Skip navigation
Universidade Federal da Bahia |
Repositório Institucional da UFBA
Use este identificador para citar ou linkar para este item: https://repositorio.ufba.br/handle/ri/15977
Tipo: Artigo de Periódico
Título: IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma
Título(s) alternativo(s): Blood
Autor(es): Ramos, Juan Carlos
Ruiz Junior., Phillip
Ratner, Lee
Reis, Isildinha M.
Brites, Carlos
Pedroso, Celia
Byrne Junior, Gerald E.
Toomey, Ngoc L.
Andela, Valentine
Harhaj, Edward W.
Lossos, Izidore S.
Harrington Junior, William J.
Autor(es): Ramos, Juan Carlos
Ruiz Junior., Phillip
Ratner, Lee
Reis, Isildinha M.
Brites, Carlos
Pedroso, Celia
Byrne Junior, Gerald E.
Toomey, Ngoc L.
Andela, Valentine
Harhaj, Edward W.
Lossos, Izidore S.
Harrington Junior, William J.
Abstract: Adult T-cell leukemia/lymphoma (ATLL) is a generally fatal malignancy. Most ATLL patients fare poorly with conventional chemotherapy; however, antiviral therapy with zidovudine (AZT) and interferon alpha (IFN-α) has produced long-term clinical remissions. We studied primary ATLL tumors and identified molecular features linked to sensitivity and resistance to antiviral therapy. Enhanced expression of the proto-oncogene c-Rel was noted in 9 of 27 tumors. Resistant tumors exhibited c-Rel (6 of 10; 60%) more often than did sensitive variants (1 of 9; 11%). This finding was independent of the disease form. Elevated expression of the putative c-Rel target, interferon regulatory factor-4 (IRF-4), was observed in 10 (91%) of 11 nonresponders and in all tested patients with c-Rel+ tumors and occurred in the absence of the HTLV-1 oncoprotein Tax. In contrast, tumors in complete responders did not express c-Rel or IRF-4. Gene rearrangement studies demonstrated the persistence of circulating T-cell clones in long-term survivors maintained on antiviral therapy. The expression of nuclear c-Rel and IRF-4 occurs in the absence of Tax in primary ATLL and is associated with antiviral resistance. These molecular features may help guide treatment. AZT and IFN-α is a suppressive rather than a curative regimen, and patients in clinical remission should remain on maintenance therapy indefinitely.
Tipo de Acesso: Acesso Aberto
URI: http://repositorio.ufba.br/ri/handle/ri/15977
Data do documento: 2007
Aparece nas coleções:Artigo Publicado em Periódico (Faculdade de Medicina)

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
10.1182blood-2006-07-036368.pdf452,07 kBAdobe PDFVisualizar/Abrir
Mostrar registro completo do item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.